You are here

Article info

Article menu

Download PDFPDF

Neurodegeneration
Research paper
Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort

Authors

  • Guro Berge Faculty of Medicine, Department of Neuroscience, Norwegian University of Science and Technology (NTNU), Trondheim, Norway PubMed articlesGoogle scholar articles
  • Sigrid B Sando Faculty of Medicine, Department of Neuroscience, Norwegian University of Science and Technology (NTNU), Trondheim, NorwayDepartment of Neurology, University Hospital of Trondheim, Trondheim, Norway PubMed articlesGoogle scholar articles
  • Arvid Rongve Department of Psychiatry, Haugesund Hospital, Haugesund, Norway PubMed articlesGoogle scholar articles
  • Dag Aarsland Department of Neurobiology, Care Sciences, and Society, Alzheimer's Disease Research Center, Karolinska Institute, Stockholm, Sweden Department of Psychiatry, Akershus University Hospital, NorwayCentre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway PubMed articlesGoogle scholar articles
  • Linda R White Faculty of Medicine, Department of Neuroscience, Norwegian University of Science and Technology (NTNU), Trondheim, NorwayDepartment of Neurology, University Hospital of Trondheim, Trondheim, Norway PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Linda Rosemary White, Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NO-7491, Norway; linda.white{at}ntnu.no
View Full Text

Citation

Berge G, Sando SB, Rongve A, et al
Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort
Journal of Neurology, Neurosurgery & Psychiatry 2014;85:1227-1231.

Publication history

  • Received November 13, 2013
  • Revised January 17, 2014
  • Accepted February 10, 2014
  • First published March 17, 2014.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/